BIOMAT Database Logo BIOMAT Database Logo

Atypical drug-induced hypersensitivity syndrome with human herpesvirus 6 reactivation due to calcium blockers. 2013

Maki Moriya, and Michiko Aihara, and Michiru Imai, and Yuko Ikezawa, and Setsuko Matsukura, and Takeshi Kanbara, and Yasuhisa Baba, and Zenro Ikezawa

UI MeSH Term Description Entries
D008297 Male Males
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D004095 Dihydropyridines Pyridine moieties which are partially saturated by the addition of two hydrogen atoms in any position.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001383 Azetidinecarboxylic Acid A proline analog that acts as a stoichiometric replacement of proline. It causes the production of abnormal proteins with impaired biological activity. 3-azetidinecarboxylic Acid,Azetidine-2-carboxylic Acid,Azetidine-3-carboxylic Acid,3 azetidinecarboxylic Acid,Azetidine 2 carboxylic Acid,Azetidine 3 carboxylic Acid
D014775 Virus Activation The mechanism by which latent viruses, such as genetically transmitted tumor viruses (PROVIRUSES) or PROPHAGES of lysogenic bacteria, are induced to replicate and then released as infectious viruses. It may be effected by various endogenous and exogenous stimuli, including B-cell LIPOPOLYSACCHARIDES, glucocorticoid hormones, halogenated pyrimidines, IONIZING RADIATION, ultraviolet light, and superinfecting viruses. Prophage Excision,Prophage Induction,Virus Induction,Viral Activation,Activation, Viral,Activation, Virus,Activations, Viral,Activations, Virus,Excision, Prophage,Excisions, Prophage,Induction, Prophage,Induction, Virus,Inductions, Prophage,Inductions, Virus,Prophage Excisions,Prophage Inductions,Viral Activations,Virus Activations,Virus Inductions
D015654 Herpesvirus 6, Human Members of the ROSEOLOVIRUS genus of the Betaherpesvirales subfamily isolated from patients with AIDS and other LYMPHOPROLIFERATIVE DISORDERS. It infects and replicates in fresh and established lines of hematopoietic cells and cells of neural origin. It also appears to alter the activity of NK CELLS. HHV-6; (HBLV) antibodies are elevated in patients with AIDS; SJOGREN'S SYNDROME; SARCOIDOSIS; CHRONIC FATIGUE SYNDROME, and certain malignancies. HHV-6A is the most common cause of EXANTHEMA SUBITUM and has been implicated in encephalitis. When HHV-6 integrates into the host genome it is referred to as ciHVH-6. When such VIRUS INTEGRATION occurs into the germline it is referred to as iciHHV-6. HBLV,Herpesvirus 6A, Human,Herpesvirus 6B, Human,Human B-Lymphotropic Virus,Chromosomally Integrated Human Herpesvirus 6,Chromosomally Integrated Human Herpesvirus 6A,Chromosomally Integrated Human Herpesvirus 6B,HHV-6,HHV-6A,HHV-6B,HHV6,HHV6A,HHV6B,Human Herpesvirus 6,Human betaherpesvirus 6,Human betaherpesvirus 6A,Human betaherpesvirus 6B,Inherited Chromosomally Integrated Human Herpesvirus 6,Inherited Chromosomally Integrated Human Herpesvirus 6A,Inherited Chromosomally Integrated Human Herpesvirus 6B,ciHHV-6,ciHHV-6A,ciHHV-6B,ciHHV6,ciHHV6A,ciHHV6B,iciHHV-6,iciHHV-6A,iciHHV-6B,iciHHV6,iciHHV6A,iciHHV6B,B-Lymphotropic Virus, Human,B-Lymphotropic Viruses, Human,Human B Lymphotropic Virus,Human B-Lymphotropic Viruses,Human Herpesvirus 6A,Human Herpesvirus 6B,Human betaherpesvirus 6s
D019349 Roseolovirus Infections Infection with ROSEOLOVIRUS, the most common in humans being EXANTHEMA SUBITUM, a benign disease of infants and young children. Infections, Roseolovirus,Infection, Roseolovirus,Roseolovirus Infection
D063926 Drug Hypersensitivity Syndrome Severe drug eruption characterized by high fever, erythematous rash and inflammation of internal organ(s). Drug Reaction With Eosinophilia And Systemic Symptom,DRESS Syndrome,Drug Reaction with Eosinophilia and Systemic Symptoms,Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome,DRESS Syndromes,Drug Hypersensitivity Syndromes,Hypersensitivity Syndrome, Drug,Hypersensitivity Syndromes, Drug,Syndrome, Drug Hypersensitivity,Syndromes, Drug Hypersensitivity

Related Publications

Maki Moriya, and Michiko Aihara, and Michiru Imai, and Yuko Ikezawa, and Setsuko Matsukura, and Takeshi Kanbara, and Yasuhisa Baba, and Zenro Ikezawa
Drug-induced hypersensitivity syndrome with human herpesvirus-6 reactivation.
January 2012, Indian journal of dermatology, venereology and leprology,
Maki Moriya, and Michiko Aihara, and Michiru Imai, and Yuko Ikezawa, and Setsuko Matsukura, and Takeshi Kanbara, and Yasuhisa Baba, and Zenro Ikezawa
ATL-like marked atypical lymphocytosis associated with drug-induced hypersensitivity syndrome and human herpesvirus-6 reactivation.
December 2009, International journal of hematology,
Maki Moriya, and Michiko Aihara, and Michiru Imai, and Yuko Ikezawa, and Setsuko Matsukura, and Takeshi Kanbara, and Yasuhisa Baba, and Zenro Ikezawa
Drug hypersensitivity syndrome and human herpesvirus 6 reactivation.
February 2002, Archives of dermatology,
Maki Moriya, and Michiko Aihara, and Michiru Imai, and Yuko Ikezawa, and Setsuko Matsukura, and Takeshi Kanbara, and Yasuhisa Baba, and Zenro Ikezawa
Drug-induced hypersensitivity syndrome associated with human herpesvirus 6 and cytomegalovirus reactivation.
December 2005, The Journal of dermatology,
Maki Moriya, and Michiko Aihara, and Michiru Imai, and Yuko Ikezawa, and Setsuko Matsukura, and Takeshi Kanbara, and Yasuhisa Baba, and Zenro Ikezawa
Drug-induced hypersensitivity syndrome due to carbamazepine associated with reactivation of human herpesvirus 7.
January 2005, Dermatology (Basel, Switzerland),
Maki Moriya, and Michiko Aihara, and Michiru Imai, and Yuko Ikezawa, and Setsuko Matsukura, and Takeshi Kanbara, and Yasuhisa Baba, and Zenro Ikezawa
Carbamazepine-induced hypersensitivity syndrome, associated with human herpesvirus 6 reactivation.
February 2004, Journal of clinical psychopharmacology,
Maki Moriya, and Michiko Aihara, and Michiru Imai, and Yuko Ikezawa, and Setsuko Matsukura, and Takeshi Kanbara, and Yasuhisa Baba, and Zenro Ikezawa
Drug-induced hypersensitivity syndrome due to mexiletine hydrochloride associated with reactivation of human herpesvirus 7.
January 2006, Dermatology (Basel, Switzerland),
Maki Moriya, and Michiko Aihara, and Michiru Imai, and Yuko Ikezawa, and Setsuko Matsukura, and Takeshi Kanbara, and Yasuhisa Baba, and Zenro Ikezawa
Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6.
September 1998, Archives of dermatology,
Maki Moriya, and Michiko Aihara, and Michiru Imai, and Yuko Ikezawa, and Setsuko Matsukura, and Takeshi Kanbara, and Yasuhisa Baba, and Zenro Ikezawa
Human herpesvirus 6 reactivation in drug-induced hypersensitivity syndrome and DRESS validation score.
July 2012, The American journal of medicine,
Maki Moriya, and Michiko Aihara, and Michiru Imai, and Yuko Ikezawa, and Setsuko Matsukura, and Takeshi Kanbara, and Yasuhisa Baba, and Zenro Ikezawa
Human herpesvirus 6 reactivation and inflammatory cytokine production in patients with drug-induced hypersensitivity syndrome.
December 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
Copied contents to your clipboard!